Zoon Kathryn C 4
4 · Emergent BioSolutions Inc. · Filed May 27, 2021
Insider Transaction Report
Form 4
Zoon Kathryn C
Director
Transactions
- Sale
Common Stock
2021-05-25$56.48/sh−3,139$177,291→ 14,377 total
Footnotes (3)
- [F1]Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated.
- [F2]All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on February 25, 2021, that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended (the "Exchange Act").
- [F3]The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $56.11 to $56.86.